1 244

Cited 0 times in

Markedly Enhanced Cytolysis by E1B-19kD-Deleted Oncolytic Adenovirus in Combination with Cisplatin

Authors
 A-Rum Yoon  ;  Joo-Hang Kim  ;  Young-Sook Lee  ;  Hoguen Kim  ;  Ji-Young Yoo  ;  Joo-Hyuk Sohn  ;  Byeong-Woo Park  ;  Chae-Ok Yun 
Citation
 Human Gene Therapy, Vol.17(4) : 379-390, 2006 
Journal Title
 Human Gene Therapy 
ISSN
 1043-0342 
Issue Date
2006
Abstract
Oncolytic adenoviruses are currently being developed as novel antitumor therapeutics. To enhance their therapeutic potential, adenoviruses are being administered in combination with standard chemotherapy. Adenoviral vectors used in these clinical trials, however, can be destructive as they encode intact E1B 19-kDa protein, which can block the apoptotic pathway induced by a variety of chemotherapeutic agents. Previously, we have shown that oncolytic adenovirus Ad-ΔE1B19/55, deleted for sequence encoding E1B 19-kDa and E1B 55-kDa proteins, exhibits marked enhancement in cytolytic and apoptotic activity [Kim, J., Cho, J.Y., Kim, J.H., Jung, K.C., and Yun, C.O. (2002). Cancer Gene Ther. 9, 725–736]. In the current study, we assess the therapeutic value of Ad- ΔE1B55 and Ad-ΔE1B19/55 in combination with cisplatin. A marked increase in cytotoxicity was observed for both Ad-ΔE1B55 and Ad-ΔE1B19/55 when combined with cisplatin. Relative to each other in all cell lines examined, the combination of the double-deleted adenovirus, Ad-ΔE1B19/55, plus cisplatin exhibited a greater cell-killing effect than did the single-deleted adenovirus, Ad-ΔE1B55, plus cisplatin. Propidium iodide staining and TUNEL analysis also revealed that the combination of cisplatin with Ad-ΔE1B19/55 caused greater induction of apoptosis than that with Ad-ΔE1B55. Similarly, in vivo, the combination of Ad-ΔE1B55 or Ad-ΔE1B19/55 with cisplatin also induced greater antitumor effect in a human cervical xenograft model. TUNEL staining showed that the apoptotic level was significantly higher in tumor tissue treated with Ad-ΔE1B19/55 plus cisplatin than with any other treatment. In addition, viral presence was confirmed by immunohistological staining, with increased numbers of adenoviral particles detected in wider areas of tumors treated with Ad-ΔE1B19/55 oncolytic adenovirus plus cisplatin. Taken together, these findings demonstrate that cisplatin in combination with E1B- 19kD-deleted oncolytic adenovirus may enhance therapeutic efficacy (via active induction of apoptosis), eliciting a greater efficacy profile than that with E1B-19kD-expressing oncolytic adenovirus.
Full Text
http://online.liebertpub.com/doi/abs/10.1089/hum.2006.17.379
DOI
10.1089/hum.2006.17.379
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
5. Research Institutes (연구소) > Institute for Cancer Research (암연구소) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
김주항(Kim, Joo Hang)
김호근(Kim, Ho Keun)
박병우(Park, Byeong Woo) ORCID logo https://orcid.org/0000-0003-1353-2607
손주혁(Sohn, Joo Hyuk) ORCID logo https://orcid.org/0000-0002-2303-2764
윤채옥(Yun, Chae Ok)
Export
RIS (EndNote)
XLS (Excel)
XML
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/108962
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse